<div id=toc></div>

# Table of Contents

- [q-bio.GN](#q-bio.GN) [Total: 1]
- [q-bio.QM](#q-bio.QM) [Total: 3]
- [cs.LG](#cs.LG) [Total: 2]
- [physics.med-ph](#physics.med-ph) [Total: 1]


<div id='q-bio.GN'></div>

# q-bio.GN [[Back]](#toc)

### [1] [A Multi-Evidence Framework Rescues Low-Power Prognostic Signals and Rejects Statistical Artifacts in Cancer Genomics](https://arxiv.org/abs/2510.18571)
*Gokturk Aytug Akarlar*

Main category: q-bio.GN

TL;DR: 开发了一个五标准计算框架，整合因果推断和生物学验证，用于在统计功效不足的癌症基因组队列中识别真实信号，避免传统GWAS方法的假阴性和假阳性问题。


<details>
  <summary>Details</summary>
Motivation: 标准癌症基因组关联研究在统计功效不足的队列中系统性地失败，在TCGA乳腺癌队列中低事件率导致严重的功效限制，产生已知驱动基因的假阴性和大乘客基因的假阳性。

Method: 开发了五标准计算框架，整合因果推断方法（逆概率加权、双重稳健估计）与正交生物学验证（表达、突变模式、文献证据）。

Result: 标准Cox+FDR方法在FDR<0.05时检测到零个基因，确认在功效不足设置中完全失败。框架正确识别RYR2为假阳性，KMT2C为需要验证的复杂候选基因。功效分析显示基因中位功效为15.1%，KMT2C仅29.8%功效。

Conclusion: 这种多证据方法为分析功效不足队列提供了模板，优先考虑生物学可解释性而非纯统计显著性。

Abstract: Motivation: Standard genome-wide association studies in cancer genomics rely
on statistical significance with multiple testing correction, but
systematically fail in underpowered cohorts. In TCGA breast cancer (n=967, 133
deaths), low event rates (13.8%) create severe power limitations, producing
false negatives for known drivers and false positives for large passenger
genes. Results: We developed a five-criteria computational framework
integrating causal inference (inverse probability weighting, doubly robust
estimation) with orthogonal biological validation (expression, mutation
patterns, literature evidence). Applied to TCGA-BRCA mortality analysis,
standard Cox+FDR detected zero genes at FDR<0.05, confirming complete failure
in underpowered settings. Our framework correctly identified RYR2 -- a cardiac
gene with no cancer function -- as a false positive despite nominal
significance (p=0.024), while identifying KMT2C as a complex candidate
requiring validation despite marginal significance (p=0.047, q=0.954). Power
analysis revealed median power of 15.1% across genes, with KMT2C achieving only
29.8% power (HR=1.55), explaining borderline statistical significance despite
strong biological evidence. The framework distinguished true signals from
artifacts through mutation pattern analysis: RYR2 showed 29.8% silent mutations
(passenger signature) with no hotspots, while KMT2C showed 6.7% silent
mutations with 31.4% truncating variants (driver signature). This
multi-evidence approach provides a template for analyzing underpowered cohorts,
prioritizing biological interpretability over purely statistical significance.
  Availability: All code and analysis pipelines available at
github.com/akarlaraytu/causal-inference-for-cancer-genomics

</details>


<div id='q-bio.QM'></div>

# q-bio.QM [[Back]](#toc)

### [2] [CBINNS: Cancer Biology-Informed Neural Network for Unknown Parameter Estimation and Missing Physics Identification](https://arxiv.org/abs/2510.17920)
*Bishal Chhetri,B. V. Rathish Kumar*

Main category: q-bio.QM

TL;DR: 开发了一种癌症生物学信息神经网络模型(CBINN)，用于从稀疏噪声数据中推断肿瘤-免疫动力学模型中的未知参数并发现缺失的物理规律。


<details>
  <summary>Details</summary>
Motivation: 肿瘤-免疫相互作用的动力学通常用微分方程建模，但这些模型存在未知参数需要估计，且由于生物复杂性，系统方程中可能存在未知或缺失项。

Method: 使用CBINN框架，在三个不同的非线性区室肿瘤-免疫模型上测试，评估其在多个合成噪声水平下的鲁棒性。

Result: CBINN模型能够有效估计未知模型参数，并发现控制这些生物系统的潜在物理规律或数学结构，即使从分散和噪声测量中也能实现。

Conclusion: 该方法在代表肿瘤-免疫相互作用常见动态模式的区室模型上验证了其通用性和有效性。

Abstract: The dynamics of tumor-immune interactions within a complex tumor
microenvironment are typically modeled using a system of ordinary differential
equations or partial differential equations. These models introduce some
unknown parameters that need to be estimated accurately and efficiently from
the limited and noisy experimental data. Moreover, due to the intricate
biological complexity and limitations in experimental measurements,
tumor-immune dynamics are not fully understood, and therefore, only partial
knowledge of the underlying physics may be available, resulting in unknown or
missing terms within the system of equations. In this study, we develop a
cancer biology-informed neural network model(CBINN) to infer the unknown
parameters in the system of equations as well as to discover the missing
physics from sparse and noisy measurements. We test the performance of the
CBINN model on three distinct nonlinear compartmental tumor-immune models and
evaluate its robustness across multiple synthetic noise levels. By harnessing
these highly nonlinear dynamics, our CBINN framework effectively estimates the
unknown model parameters and uncovers the underlying physical laws or
mathematical structures that govern these biological systems, even from
scattered and noisy measurements. The models chosen here represent the dynamic
patterns commonly observed in compartmental models of tumor-immune
interactions, thereby validating the generalizability and efficacy of our
methodology.

</details>


### [3] [Protein generation with embedding learning for motif diversification](https://arxiv.org/abs/2510.18790)
*Kevin Michalewicz,Chen Jin,Philip Alexander Teare,Tom Diethe,Mauricio Barahona,Barbara Bravi,Asher Mullokandov*

Main category: q-bio.QM

TL;DR: PGEL是一个蛋白质生成框架，通过在扩散模型的嵌入空间中学习目标基序的特征表示并引入受控扰动，解决了蛋白质设计中结构多样性与功能保持的权衡问题。


<details>
  <summary>Details</summary>
Motivation: 现有方法如RFdiffusion中的部分扩散无法平衡结构多样性与基序生物功能保持的权衡，小扰动产生与天然结构几乎相同的基序，而大扰动则违反几何约束。

Method: PGEL学习目标基序序列和结构特征的高维嵌入表示，在扩散模型冻结去噪器的表示空间中引入受控扰动来增强基序多样性。

Result: 在单体、蛋白质-蛋白质界面和癌症相关转录因子复合物三个代表性案例中，PGEL相比部分扩散实现了更大的结构多样性、更好的可设计性和改进的自一致性。

Conclusion: PGEL作为一种通用的嵌入驱动蛋白质生成策略，能够系统性地实现功能基序的可行多样化。

Abstract: A fundamental challenge in protein design is the trade-off between generating
structural diversity while preserving motif biological function. Current
state-of-the-art methods, such as partial diffusion in RFdiffusion, often fail
to resolve this trade-off: small perturbations yield motifs nearly identical to
the native structure, whereas larger perturbations violate the geometric
constraints necessary for biological function. We introduce Protein Generation
with Embedding Learning (PGEL), a general framework that learns
high-dimensional embeddings encoding sequence and structural features of a
target motif in the representation space of a diffusion model's frozen
denoiser, and then enhances motif diversity by introducing controlled
perturbations in the embedding space. PGEL is thus able to loosen geometric
constraints while satisfying typical design metrics, leading to more diverse
yet viable structures. We demonstrate PGEL on three representative cases: a
monomer, a protein-protein interface, and a cancer-related transcription factor
complex. In all cases, PGEL achieves greater structural diversity, better
designability, and improved self-consistency, as compared to partial diffusion.
Our results establish PGEL as a general strategy for embedding-driven protein
generation allowing for systematic, viable diversification of functional
motifs.

</details>


### [4] [Triangle Multiplication Is All You Need For Biomolecular Structure Representations](https://arxiv.org/abs/2510.18870)
*Jeffrey Ouyang-Zhang,Pranav Murugan,Daniel J. Diaz,Gianluca Scarpellini,Richard Strong Bowen,Nate Gruver,Adam Klivans,Philipp Krähenbühl,Aleksandra Faust,Maruan Al-Shedivat*

Main category: q-bio.QM

TL;DR: Pairmixer是一个高效的蛋白质结构预测模型，通过消除三角注意力机制来替代AlphaFold3中的Pairformer主干，在保持几何推理能力的同时显著提升计算效率。


<details>
  <summary>Details</summary>
Motivation: AlphaFold在蛋白质结构预测方面取得了突破，但在大规模应用如虚拟配体筛选、全蛋白质组折叠和从头设计时，计算成本和内存需求过高。Pairformer主干中的三角注意力机制成为主要瓶颈。

Method: 提出Pairmixer作为Pairformer的简化替代方案，消除计算昂贵的三角注意力，同时保留对结构预测至关重要的高阶几何推理能力。

Result: Pairmixer在折叠和对接基准测试中达到最先进水平，在长序列上推理速度提升4倍，训练成本降低34%。在BoltzDesign中采样速度提升2倍以上，可处理比Pairformer内存限制长30%的序列。

Conclusion: Pairmixer通过消除三角注意力机制显著提高了计算效率，缓解了下游应用的计算负担，为大规模蛋白质建模和设计提供了可行的解决方案。

Abstract: AlphaFold has transformed protein structure prediction, but emerging
applications such as virtual ligand screening, proteome-wide folding, and de
novo binder design demand predictions at a massive scale, where runtime and
memory costs become prohibitive. A major bottleneck lies in the Pairformer
backbone of AlphaFold3-style models, which relies on computationally expensive
triangular primitives-especially triangle attention-for pairwise reasoning. We
introduce Pairmixer, a streamlined alternative that eliminates triangle
attention while preserving higher-order geometric reasoning capabilities that
are critical for structure prediction. Pairmixer substantially improves
computational efficiency, matching state-of-the-art structure predictors across
folding and docking benchmarks, delivering up to 4x faster inference on long
sequences while reducing training cost by 34%. Its efficiency alleviates the
computational burden of downstream applications such as modeling large protein
complexes, high-throughput ligand and binder screening, and hallucination-based
design. Within BoltzDesign, for example, Pairmixer delivers over 2x faster
sampling and scales to sequences ~30% longer than the memory limits of
Pairformer.

</details>


<div id='cs.LG'></div>

# cs.LG [[Back]](#toc)

### [5] [Enhancing mortality prediction in cardiac arrest ICU patients through meta-modeling of structured clinical data from MIMIC-IV](https://arxiv.org/abs/2510.18103)
*Nursultan Mamatov,Philipp Kellmeyer*

Main category: cs.LG

TL;DR: 开发结合结构化临床数据和文本信息的机器学习模型，用于ICU住院死亡率早期预测，相比仅使用结构化数据，AUC从0.753提升至0.918。


<details>
  <summary>Details</summary>
Motivation: ICU住院死亡率的准确早期预测对于及时临床干预和资源分配至关重要。

Method: 使用LASSO和XGBoost进行特征选择，然后基于两种模型识别的重要特征训练多元逻辑回归。使用TF-IDF和BERT嵌入整合文本特征。

Result: 结合结构和文本输入的最终逻辑回归模型AUC达到0.918，相比仅使用结构化数据的0.753，相对提升22%。决策曲线分析显示在广泛阈值概率范围内具有优越的标准化净收益。

Conclusion: 非结构化临床记录具有额外的预后价值，应整合到可解释的特征驱动风险预测模型中用于ICU患者。

Abstract: Accurate early prediction of in-hospital mortality in intensive care units
(ICUs) is essential for timely clinical intervention and efficient resource
allocation. This study develops and evaluates machine learning models that
integrate both structured clinical data and unstructured textual information,
specifically discharge summaries and radiology reports, from the MIMIC-IV
database. We used LASSO and XGBoost for feature selection, followed by a
multivariate logistic regression trained on the top features identified by both
models. Incorporating textual features using TF-IDF and BERT embeddings
significantly improved predictive performance. The final logistic regression
model, which combined structured and textual input, achieved an AUC of 0.918,
compared to 0.753 when using structured data alone, a relative improvement 22%.
The analysis of the decision curve demonstrated a superior standardized net
benefit in a wide range of threshold probabilities (0.2-0.8), confirming the
clinical utility of the model. These results underscore the added prognostic
value of unstructured clinical notes and support their integration into
interpretable feature-driven risk prediction models for ICU patients.

</details>


### [6] [HeFS: Helper-Enhanced Feature Selection via Pareto-Optimized Genetic Search](https://arxiv.org/abs/2510.18575)
*Yusi Fan,Tian Wang,Zhiying Yan,Chang Liu,Qiong Zhou,Qi Lu,Zhehao Guo,Ziqi Deng,Wenyu Zhu,Ruochi Zhang,Fengfeng Zhou*

Main category: cs.LG

TL;DR: HeFS框架通过遗传算法和多目标优化来改进现有特征选择算法，识别被忽略但信息丰富的特征，在多个基准数据集上优于现有方法。


<details>
  <summary>Details</summary>
Motivation: 传统特征选择方法容易过早收敛，难以捕捉复杂特征关系，特别是在高维数据中。

Method: 使用偏置初始化方案和比率引导变异机制的遗传算法，结合基于Pareto的多目标优化来最大化预测精度和特征互补性。

Result: 在18个基准数据集上的实验表明，HeFS能持续识别被忽略的信息特征，在胃癌分类、药物毒性预测等领域表现优于现有方法。

Conclusion: HeFS框架能有效改进特征选择结果，识别互补特征，提升分类性能。

Abstract: Feature selection is a combinatorial optimization problem that is NP-hard.
Conventional approaches often employ heuristic or greedy strategies, which are
prone to premature convergence and may fail to capture subtle yet informative
features. This limitation becomes especially critical in high-dimensional
datasets, where complex and interdependent feature relationships prevail. We
introduce the HeFS (Helper-Enhanced Feature Selection) framework to refine
feature subsets produced by existing algorithms. HeFS systematically searches
the residual feature space to identify a Helper Set - features that complement
the original subset and improve classification performance. The approach
employs a biased initialization scheme and a ratio-guided mutation mechanism
within a genetic algorithm, coupled with Pareto-based multi-objective
optimization to jointly maximize predictive accuracy and feature
complementarity. Experiments on 18 benchmark datasets demonstrate that HeFS
consistently identifies overlooked yet informative features and achieves
superior performance over state-of-the-art methods, including in challenging
domains such as gastric cancer classification, drug toxicity prediction, and
computer science applications. The code and datasets are available at
https://healthinformaticslab.org/supp/.

</details>


<div id='physics.med-ph'></div>

# physics.med-ph [[Back]](#toc)

### [7] [Quantification of dual-state 5-ALA-induced PpIX fluorescence: Methodology and validation in tissue-mimicking phantoms](https://arxiv.org/abs/2510.18387)
*Silvère Ségaud,Charlie Budd,Matthew Elliot,Graeme Stasiuk,Jonathan Shapey,Yijing Xie,Tom Vercauteren*

Main category: physics.med-ph

TL;DR: 提出了一种用于胶质瘤中原卟啉IX（PpIX）荧光定量分析的新方法，能够准确区分两种发射状态与背景自发荧光，并校正光学畸变。


<details>
  <summary>Details</summary>
Motivation: 现有定量荧光系统使用简化的模型，无法同时模拟荧光团与组织光学特性或微环境的复杂相互作用，存在系统性误差风险。

Method: 开发了新型组织模拟模型，复制胶质瘤组织的光学特性和PpIX荧光的光化学变异性。通过无监督方法区分PpIX发射状态，并进行波长依赖性光学畸变校正。

Result: 该方法与真实PpIX浓度呈现强相关性（R² = 0.918±0.002）。

Conclusion: 该工作流程在临床环境中具有实现稳健、定量PpIX荧光成像的潜力。

Abstract: Quantification of protoporphyrin IX (PpIX) fluorescence in human brain
tumours has the potential to significantly improve patient outcomes in
neuro-oncology, but represents a formidable imaging challenge. Protoporphyrin
is a biological molecule which interacts with the tissue micro-environment to
form two photochemical states in glioma. Each exhibits markedly different
quantum efficiencies, with distinct but overlapping emission spectra that also
overlap with tissue autofluorescence. Fluorescence emission is known to be
distorted by the intrinsic optical properties of tissue, coupled with marked
intra-tumoural heterogeneity as a hallmark of glioma tumours. Existing
quantitative fluorescence systems are developed and validated using simplified
phantoms that do not simultaneously mimic the complex interactions between
fluorophores and tissue optical properties or micro-environment. Consequently,
existing systems risk introducing systematic errors into PpIX quantification
when used in tissue. In this work, we introduce a novel pipeline for
quantification of PpIX in glioma, which robustly differentiates both emission
states from background autofluorescence without reliance on a priori spectral
information, and accounts for variations in their quantum efficiency. Unmixed
PpIX emission forms are then corrected for wavelength-dependent optical
distortions and weighted for accurate quantification. Significantly, this
pipeline is developed and validated using novel tissue-mimicking phantoms
replicating the optical properties of glioma tissues and photochemical
variability of PpIX fluorescence in glioma. Our workflow achieves strong
correlation with ground-truth PpIX concentrations (R2 = 0.918+-0.002),
demonstrating its potential for robust, quantitative PpIX fluorescence imaging
in clinical settings.

</details>
